Skip to content
Trial Eligibility
Menu

Lung Cancer Clinical Trials near New Haven, CT

127 studies for Lung Cancer are recruiting at 315 sites within 50 miles of New Haven, Connecticut, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Lung Cancer trials in the US or all trials near New Haven.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Lung Cancer studies enrolling near New Haven

Showing the 50 nearest of 127 studies.
  1. Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

    NCT03851445

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Smilow Cancer Center/Yale-New Haven Hospital (New Haven, CT); Yale University (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    20 sites within 50 mi
  2. Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

    NCT04181060

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Yale University (New Haven, CT); Yale-New Haven Hospital North Haven Medical Center (North Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    19 sites within 50 mi
  3. Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

    NCT04267848

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Yale University (New Haven, CT); Veterans Affairs Connecticut Healthcare System-West Haven Campus (West Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    16 sites within 50 mi
  4. Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

    NCT06031688

    • Phase 2
    • Ages 18 Minutes and older
    • Sex: All

    Nearest sites: Yale University (New Haven, CT); Yale-New Haven Hospital North Haven Medical Center (North Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    15 sites within 50 mi
  5. Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

    NCT05642572

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Yale University (New Haven, CT); Smilow Cancer Hospital-Orange Care Center (Orange, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    14 sites within 50 mi
  6. Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

    NCT06616584

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Yale University (New Haven, CT); Veterans Affairs Connecticut Healthcare System-West Haven Campus (West Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    14 sites within 50 mi
  7. Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

    NCT06769126

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Yale University (New Haven, CT); Yale-New Haven Hospital North Haven Medical Center (North Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    9 sites within 50 mi
  8. Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

    NCT06116682

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Yale University (New Haven, CT); Yale-New Haven Hospital North Haven Medical Center (North Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  9. Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer

    NCT04210492

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Smilow Cancer Hospital (New Haven, CT); Smilow Cancer Hospital - Hamden Care Center (Hamden, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  10. Phase 1 Study of PF-08046033 in Advanced Solid Tumors

    NCT07519655

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Smilow Cancer Hospital - Yale New Haven Health (New Haven, CT); Smilow Cancer Hospital Phase 1 Unit (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  11. Study of PF-07248144 in Advanced or Metastatic Solid Tumors

    NCT04606446

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Smilow Cancer Hospital Phase 1 Unit (New Haven, CT); Smilow Cancer Hospital at Yale - New Haven (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  12. A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

    NCT07090499

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Smilow Cancer Hospital - Yale New Haven Health (New Haven, CT); Smilow Cancer Hospital Phase 1 Unit (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  13. Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

    NCT06287775

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Yale University (New Haven, CT); Yale-New Haven Hospital North Haven Medical Center (North Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  14. A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

    NCT06623422

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Yale University School of Medicine ( Site 0201) (New Haven, CT); Eastern CT Hematology & Oncology Associates ( Site 0202) (Norwich, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  15. Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

    NCT06343402

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Yale Cancer Center (New Haven, CT); Norwalk Hospital (Norwalk, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  16. A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

    NCT06667076

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Yale New Haven Hospital Yale Cancer Center (New Haven, CT); New York Cancer and Blood Specialists (Shirley, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  17. A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

    NCT07070232

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Yale University (New Haven, CT); Hartford Healthcare (Hartford, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  18. A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

    NCT07218146

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Yale Cancer Center/Clinical Trials Office (New Haven, CT); Stony Brook Cancer Center (Stony Brook, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  19. A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

    NCT07513376

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Smilow Cancer Center at Yale-New Haven ( Site 3253) (New Haven, CT); White Plains Hospital ( Site 3213) (White Plains, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  20. A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

    NCT04302025

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale Cancer Center (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

    NCT04585750

    • Phase 1/2
    • Ages 12 years and older
    • Sex: All

    Nearest site: Yale Cancer Center (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

    NCT04777994

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale University School of Medicine /ID# 225707 (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

    NCT04787042

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale Cancer Center (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

    NCT05061550

    • Phase 2
    • Ages 18 to 95 years
    • Sex: All

    Nearest site: Research Site (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

    NCT05098132

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale New Haven Hospital, Yale Cancer Center (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

    NCT05176483

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Exelixis Clinical Site #62 (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  27. Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

    NCT05433142

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Xencor Investigative Site (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  28. A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

    NCT05652686

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale University Cancer Center (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  29. A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

    NCT05669430

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale University (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  30. Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

    NCT05786924

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale University School of Medicine - Yale Cancer Center (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  31. A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation

    NCT05789082

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale Cancer Center (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  32. A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

    NCT05902988

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale Cancer Center (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  33. Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

    NCT05983432

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale University, Yale Cancer Center (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  34. Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

    NCT06040541

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Smilow Cancer Hospital (Yale University) (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  35. A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

    NCT06119581

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale University School of Medicine (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  36. A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

    NCT06172478

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale Cancer Center (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  37. A Study of ZL-1310 in Subjects With Small Cell Lung Cancer

    NCT06179069

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale Cancer Center (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  38. Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers

    NCT06196008

    • Interventional
    • Ages 18 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Yale New Haven Medical Center (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  39. Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

    NCT06350097

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Research Site (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  40. The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP)

    NCT06412172

    • Observational
    • Ages 18 to 99 years
    • Sex: All

    Nearest site: Yale School of Medicine (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  41. A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

    NCT06568939

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale New Haven Hospital /ID# 271584 (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  42. First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

    NCT06657222

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale Cancer Center (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  43. A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

    NCT06667908

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale University (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  44. A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

    NCT06706076

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale University - Cancer Center (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  45. A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors

    NCT06747585

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale Comprehensive Cancer Center (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  46. Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

    NCT06881784

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale University, Smillow Cancer Center (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  47. BBO-11818 in Adult Subjects With KRAS Mutant Cancer

    NCT06917079

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale University (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  48. AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

    NCT07038343

    • Phase 1/2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Avenzo Therapeutics Recruiting Site (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  49. Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

    NCT07080242

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale Cancer Center (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  50. Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC

    NCT07098988

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Yale Cancer Center (New Haven, CT)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Lung Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.